Integrating Genetics into the Clinical Workflow
Dramatic advancements in clinical genetics have strained the information technology on which healthcare operates. A key focal point is the clinical care workflow. As physicians, genetic counselors, and other providers strive to deliver genomic-informed care to their patients, a number of practical challenges arise. These challenges limit the potential of genomic medicine.
- Integrating genetic test ordering/results into the electronic health record (EHR)
- Accessing practice guidelines and clinical decision support (CDS) to inform diagnostic and therapeutic decisions
- Leveraging the insights from past test results to inform clinical decisions (e.g., using pharmacogenomic information repeatedly)
- Using clinical test results to match patients to new therapies and clinical trials
- Making real-world data available for research and continuous improvement
These challenges vary in their severity depending on the clinical specialty and setting, but the big-picture vision of precision medicine cannot be accomplished without addressing them all.
In this 75-minute webinar, leading experts from across various clinical domains will discuss the state of precision medicine from the standpoint of the clinical workflow, highlight examples of success (EHR integration, genomic CDS, etc.), and identify specific opportunities to improve.
Complete the form on this page to register.
Massachusetts General Hospital
Heidi Rehm is the Chief Genomics Officer in the Department of Medicine and at the Center for Genomic Medicine at Massachusetts General Hospital working to integrate genomics into medical practice with standardized approaches. She is a board-certified laboratory geneticist, Medical Director of the Broad Institute Clinical Research Sequencing Platform and Professor of Pathology at Harvard Medical School, using these roles to guide genomic testing for clinical and clinical research use.
Rehm is a principal investigator of ClinGen, providing free and publicly accessible resources to support the interpretation of genes and variants. She also co-leads the Broad Center for Mendelian Genomics, focused on novel gene discovery, the Genome Aggregation Database and the Broad-LMM-Color All of Us Genome Center supporting the sequencing and return of results to a cohort of one million individuals in the US. She is a strong advocate and pioneer of open science and data sharing, working to extend these approaches through her role as vice chair of the Global Alliance for Genomics and Health.
Kristine Ashcraft, BS, MBA is a molecular biologist by training and is the former CEO and founder of YouScript, recently acquired by Invitae. She has worked in pharmacogenomics since 2000 and was recently named one of the 25 leading voices in precision medicine. Kristine has authored multiple publications on the clinical and economic benefits of pharmacogenomic testing including one lauded as one of the most influential publications at an American Medical Informatics Association meeting.
She has been interviewed by numerous media outlets including the New York Times, the Wall Street Journal, and NBC Nightly News and has spoken at SXSW, American Society of Human Genetics, and numerous precision medicine conferences. She is committed to being a catalyst in the adoption of precision medicine.
Mick Correll is the President of Genospace, the leading information platform for applied precision medicine. As co-founder and CEO, Mick led Genospace to a successful merger with Sarah Cannon, the Cancer Institute of Hospital Corporation of America. Over his career Mick has held leadership positions in academia and industry and has developed informatics solutions for pharma/biotech, ag bio, and academic, government, and community healthcare providers.
Prior to launching Genospace, Mick was the Associate Director of the Center for Cancer Computational Biology at the Dana-Farber Cancer Institute. Mick began his career at Lion Bioscience Research Inc. and UK-based informatics provider InforSense. Mick earned a BS in Computer Science and BA in Molecular Biology from the University of Colorado at Boulder.
The Lewin Group
Cliff Goodman is Senior Vice President at The Lewin Group, the consulting business unit within OptumServe, the federal health services business of Optum and UnitedHealth Group. He has 30 years of experience working with government, industry and nonprofit organizations in such areas as health technology assessment, comparative effectiveness research, health economics, and studies pertaining to health care innovation, regulation, and payment for pharmaceuticals, biologics, medical devices, and other interventions. Other recent areas include pharmacogenomics, diagnostic testing, personalized medicine, organ donation and transplantation, and policy applications of cost-effectiveness analysis.
Cliff served as Chair of the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) for the Centers for Medicare & Medicaid Services (2009-2012). He is Past President of the professional society, Health Technology Assessment International (HTAi), and is a Fellow of the American Institute for Medical and Biological Engineering.